Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
R. Freynhagen, C. Elling, T. Radic, M. Sohns, H. Liedgens, D. James, R. McCool & M. Edwards. (2021) Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials. Current Medical Research and Opinion 37:1, pages 89-100.
Read now
Read now
Otakhon Matchanov & Priscilla Nelson. (2020) Perioperative Serotonin Syndrome Manifesting as Gastrocnemius Myofasciculations: A Case Report. The Neurodiagnostic Journal 60:3, pages 165-176.
Read now
Read now
Jian-Ming Peng, You-Jiang Yu, Lan-Di Su & Xue Luo. (2014) Meta-analysis of 5-hydroxytryptamine type 2A receptor polymorphisms and migraine susceptibility. International Journal of Neuroscience 124:12, pages 882-889.
Read now
Read now
Santiago Perez-Lloret & Olivier Rascol. (2011) Safety of rasagiline for the treatment of Parkinson's disease. Expert Opinion on Drug Safety 10:4, pages 633-643.
Read now
Read now
Yee-Chi Lee & Phoon-Ping Chen. (2010) A review of SSRIs and SNRIs in neuropathic pain. Expert Opinion on Pharmacotherapy 11:17, pages 2813-2825.
Read now
Read now
Articles from other publishers (101)
Robert Lalonde & Catherine Strazielle. (2024) The Neuroanatomical Basis of the 5-HT Syndrome and Harmalineinduced
Tremor. Current Reviews in Clinical and Experimental Pharmacology 19:2, pages 163-172.
Crossref
Crossref
Chiara Elli, Alessio Novella & Luca Pasina. (2023) Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels. European Journal of Clinical Pharmacology.
Crossref
Crossref
Andrew Blumenfeld, Stewart J. Tepper, Rashna Khanna, Erin Doty, Maurice Vincent & Sheila I. Miller. (2023) Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience. Frontiers in Neurology 14.
Crossref
Crossref
Justin P. Reinert & Paul Brady. (2023) Wernicke’s Encephalopathy and Serotonin Syndrome: A Case Report of Overlapping Pathologies. Journal of Pharmacy Technology.
Crossref
Crossref
Stephanie Karzon AbramsBrenden Samuel RabinovitchRayyan ZafarAly Shah AzizNicholas Paul CherupDavid W. McMillanJessica L. NielsonEvan Cole Lewis. (2023) Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics. Neurotrauma Reports 4:1, pages 543-550.
Crossref
Crossref
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
Ahmed Nagy, Aishah Nasir, Mahfujul Haque, Ramzan Judge & Joseph Lee. (2023) Therapeutic cyproheptadine regimen in serotonin syndrome: Complications after cardiovascular surgery. Clinical Case Reports 11:7.
Crossref
Crossref
Arzum Erdem, Esma Yildiz, Huseyin Senturk & Meltem Maral. (2023) Implementation of 3D printing technologies to electrochemical and optical biosensors developed for biomedical and pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis 230, pages 115385.
Crossref
Crossref
Mina Cvjetković-Bošnjak, Željko Bibić & Dušan Kuljančić. (2023) Serotonin syndrome in a patient with dual diagnosis: Case study. Sanamed:00, pages 35-35.
Crossref
Crossref
Bianca Codrina Morarasu, Adorata Elena Coman, Cristina Bologa, Catalina Lionte, Ovidiu Rusalim Petris, Alexandr Ceasovschih, Victorita Sorodoc, Raluca Ecaterina Haliga, Gabriela Puha, Alexandra Stoica, Oana Sirbu, Mihai Constantin & Laurentiu Sorodoc. (2022) Recognition and Management of Serotonin Toxidrome in the Emergency Department—Case Based Review. Journal of Personalized Medicine 12:12, pages 2069.
Crossref
Crossref
Neziha Erken, Derya Kaya, Fatma Sena Dost, Esra Ates Bulut & Ahmet Turan Isik. (2022)
Antidepressant‐induced
serotonin syndrome in older patients: a
cross‐sectional
study
. Psychogeriatrics 22:4, pages 502-508.
Crossref
Crossref
Rumen Nikolov & Kalina Koleva. 2022. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics.
O. Plé, O. Mathieu, P.-A. Peyron & E. Baccino. (2022) Décès secondaire à une injection intraveineuse lente de Tramadol lors d’une prise en charge médicale : à propos d’un cas. La Revue de Médecine Légale 13:2, pages 79-85.
Crossref
Crossref
Ryuichi Ohta & Chiaki Sano. (2022) Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report. Cureus.
Crossref
Crossref
Elias Wagner, Florian Seemüller & Alkomiet Hasan. (2022) 60 Years of Combining Tranylcypromine. Journal of Clinical Psychopharmacology 42:1, pages 51-70.
Crossref
Crossref
Paul Gee & Leo J. Schep. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
301
332
.
Mark Forrest Gordon, Adena N. Leder & Laura A. Ketigian. 2022. Movement Disorder Emergencies. Movement Disorder Emergencies
139
169
.
Olga Gordeeva & Vitaliy Safandeev. (2021) 5-Hydroxytryptophan (5-HTP)-induced intracellular syndrome in mouse non-neural embryonic cells is associated with inhibited proliferation and cell death. Neuropharmacology 195, pages 107862.
Crossref
Crossref
Saud Alrashdi, Vibhu Paudyal, Mohamed Hassan Elnaem & Ejaz Cheema. (2021) Causes, Nature and Toxicology of Tramadol-Associated Deaths Reported in the Peer-Reviewed Literature: A Systematic Review of Case Studies and Case Series. Drugs & Therapy Perspectives 37:9, pages 422-432.
Crossref
Crossref
Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, John Martin Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Di Giannantonio Massimo & Amira Guirguis. (2021) New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Experimental Neurology 339, pages 113638.
Crossref
Crossref
Eleonora Gianti & Randy J. Zauhar. 2021. Remington. Remington
129
153
.
Maureen Early, Logan Wink, Craig A. Erickson & Christopher J. McDougle. 2021. Encyclopedia of Autism Spectrum Disorders. Encyclopedia of Autism Spectrum Disorders
4298
4301
.
Luca Cerniglia, Silvia Cimino, Eleonora Marzilli, Esterina Pascale & Renata Tambelli. (2020) Associations Among Internet Addiction, Genetic Polymorphisms, Family Functioning, and Psychopathological Risk: Cross-Sectional Exploratory Study. JMIR Mental Health 7:12, pages e17341.
Crossref
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
K. Koleva, O. Pavlov, R. Nikolov & R. Behr. (2020) Deep brain stimulation as a possible treatment of hyperthermia in patients with serotonin syndrome. Medical Hypotheses 139, pages 109704.
Crossref
Crossref
Timothy R. Hudd, Christie S. Blake, Yahiada Rimola-Dejesus, Thu-Trang Nguyen & Kathy Zaiken. (2019) A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy. Journal of Pharmacy Practice 33:2, pages 206-212.
Crossref
Crossref
Dario Bugada, Valentina Bellini, Elena G. Bignami & Luca F. Lorini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
633
647
.
Jesús Troya, Amalia Martínez de Gándara, Pablo Ryan, Guillermo Cuevas & Virginia Pardo. (2019) Mephedrone and chemsex: when it stops being a party and becomes a fatal problem. International Journal of STD & AIDS 30:10, pages 1028-1030.
Crossref
Crossref
F. Ložek, I. Kuklina, K. Grabicová, J. Kubec, M. Buřič, R. Grabic, T. Randák, P. Císař & P. Kozák. (2019) Behaviour and cardiac response to stress in signal crayfish exposed to environmental concentrations of tramadol. Aquatic Toxicology 213, pages 105217.
Crossref
Crossref
James Francescangeli, Kunal Karamchandani, Meghan Powell & Anthony Bonavia. (2019) The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. International Journal of Molecular Sciences 20:9, pages 2288.
Crossref
Crossref
L. Jurek, M. Nourredine, B. Megarbane, T. d’Amato, J.-M. Dorey & B. Rolland. (2019) Le syndrome sérotoninergique : une revue actualisée de la littérature. La Revue de Médecine Interne 40:2, pages 98-104.
Crossref
Crossref
Dario Bugada, Valentina Bellini, Elena G. Bignami & Luca F. Lorini. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics
1
16
.
Dianne Clifton & Jane Fletcher. 2019. Textbook of Palliative Care. Textbook of Palliative Care
1527
1562
.
Zachary D. Zuschlag, Matthew W. Warren & Susan K. Schultz. (2018) Serotonin Toxicity and Urinary Analgesics: A Case Report and Systematic Literature Review of Methylene Blue-Induced Serotonin Syndrome. Psychosomatics 59:6, pages 539-546.
Crossref
Crossref
Hai-Quyen Tran, Youngho Lee, Eun-Joo Shin, Choon-Gon Jang, Ji Hoon Jeong, Akihiro Mouri, Kuniaki Saito, Toshitaka Nabeshima & Hyoung-Chun Kim. (2018) PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis. Molecular Neurobiology 55:10, pages 7802-7821.
Crossref
Crossref
Yuki Higuchi, Tomoko Soga & Ishwar S. Parhar. (2018) Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Sarah Hasan Siddiqui, Nadeem Ahmed Memon & Ravi Shanker. (2018) Drug-induced movement disorder and confusion associated with duloxetine. BMJ Case Reports, pages bcr-2016-216746.
Crossref
Crossref
Jakob A. Shimshoni, Eyal Sobol, Ezekiel Golan, Yulius Ben Ari & Orit Gal. (2018) Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent. Toxicology and Applied Pharmacology 343, pages 29-39.
Crossref
Crossref
Ariane Stollenwerk, Melanie Sohns, Fabian Heisig, Christian Elling & Detlef von Zabern. (2017) Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic. Advances in Therapy 35:1, pages 12-30.
Crossref
Crossref
Dianne Clifton & Jane Fletcher. 2019. Textbook of Palliative Care. Textbook of Palliative Care
1
37
.
Yuki Higuchi, Tomoko Soga & Ishwar S. Parhar. (2017) Regulatory Pathways of Monoamine Oxidase A during Social Stress. Frontiers in Neuroscience 11.
Crossref
Crossref
James J. LynchIIIIII, Terry R. Van Vleet, Scott W. Mittelstadt & Eric A.G. Blomme. (2017) Potential functional and pathological side effects related to off-target pharmacological activity. Journal of Pharmacological and Toxicological Methods 87, pages 108-126.
Crossref
Crossref
N Malek & M R Baker. (2017) Common toxidromes in movement disorder neurology. Postgraduate Medical Journal 93:1100, pages 326-332.
Crossref
Crossref
Michael Entzeroth & Anil K. Ratty. (2017) Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle. Open Journal of Depression 06:02, pages 31-68.
Crossref
Crossref
Karen MiottoArthur K. ChoMohamed A. KhalilKirsten BlancoJun D. SasakiRichard Rawson. (2017) Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesthesia & Analgesia 124:1, pages 44-51.
Crossref
Crossref
Peter R. Chai & Edward W. Boyer. 2017. Critical Care Toxicology. Critical Care Toxicology
539
548
.
Ursula Werneke, Fariba Jamshidi, David M. Taylor & Michael Ott. (2016) Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases. BMC Neurology 16:1.
Crossref
Crossref
Raven Renèe Ray & Kerry S. Lassiter. (2016) Ayahuasca Treatment Center Safety for the Western Seeker. Anthropology of Consciousness 27:2, pages 121-150.
Crossref
Crossref
Meredith R. Brooks & Brenda Golianu. (2016) Perioperative management in children with chronic pain. Pediatric Anesthesia 26:8, pages 794-806.
Crossref
Crossref
Peter R. Chai & Edward W. Boyer. 2016. Critical Care Toxicology. Critical Care Toxicology
1
10
.
Julien P. N. Papillon, Changgang Lou, Alok K. Singh, Christopher M. Adams, Gary M. Ksander, Michael E. Beil, Wei Chen, Jennifer Leung-Chu, Fumin Fu, Lu Gan, Chii-Whei Hu, Arco Y. Jeng, Daniel LaSala, Guiqing Liang, Dean F. Rigel, Kerry S. Russell, John A. Vest & Catherine Watson. (2015)
Discovery of
N
-[5-(6-Chloro-3-cyano-1-methyl-1
H
-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects
. Journal of Medicinal Chemistry 58:23, pages 9382-9394.
Crossref
Crossref
Alexander Chen & Michael A. Ashburn. (2015) Cardiac Effects of Opioid Therapy. Pain Medicine 16:suppl 1, pages S27-S31.
Crossref
Crossref
Rabia Ellahi. (2018) Serotonin syndrome: a spectrum of toxicity. BJPsych Advances 21:5, pages 324-332.
Crossref
Crossref
Ryan R. Gaffney & Ian R. Schreibman. (2015) Serotonin Syndrome in a Patient on Trazodone and Duloxetine Who Received Fentanyl following a Percutaneous Liver Biopsy. Case Reports in Gastroenterology 9:2, pages 132-136.
Crossref
Crossref
Andreas Hartmann, Steven Whitebread, Jacques Hamon, Alexander Fekete, Christian Trendelenburg, Patrick Y. Müller & László Urbán. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
457
478
.
Paul Jhun, Aaron Bright & Mel Herbert. (2015) Serotonin Syndrome and Opioids?What?s the Deal?. Annals of Emergency Medicine 65:4, pages 434-435.
Crossref
Crossref
Robert Haberzettl, Heidrun Fink & Bettina Bert. (2015) The murine serotonin syndrome – Evaluation of responses to 5-HT-enhancing drugs in NMRI mice. Behavioural Brain Research 277, pages 204-210.
Crossref
Crossref
M. Barann, U. M. Stamer, M. Lyutenska, F. Stüber, H. Bönisch & B. Urban. (2014) Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg's Archives of Pharmacology 388:1, pages 43-49.
Crossref
Crossref
Ashley D. Hillman, Corey J. Witenko, Said M. Sultan & Gary Gala. (2015) Serotonin Syndrome Caused by Fentanyl and Methadone in a Burn Injury. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:1, pages 112-117.
Crossref
Crossref
Robert Haberzettl, Heidrun Fink & Bettina Bert. (2014) Role of 5-HT1A- and 5-HT2A receptors for the murine model of the serotonin syndrome. Journal of Pharmacological and Toxicological Methods 70:2, pages 129-133.
Crossref
Crossref
Tomás Herraiz & Simon D. Brandt. (2013) 5‐(2‐Aminopropyl)indole (5‐IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug Testing and Analysis 6:7-8, pages 607-613.
Crossref
Crossref
Seval Izdes, Neriman Defne Altintas & Cem Soykut. (2014) Serotonin Syndrome Caused by Administration of Methylene Blue to a Patient Receiving Selective Serotonin Reuptake Inhibitors. A & A Case Reports 2:9, pages 111-112.
Crossref
Crossref
Bradford B. Walters. 2014. Mann's Pharmacovigilance. Mann's Pharmacovigilance
585
609
.
Susie H. Park, Robin C. Wackernah & Glen L. Stimmel. (2013) Serotonin Syndrome. Journal of Pharmacy Practice 27:1, pages 71-78.
Crossref
Crossref
Robert Haberzettl, Bettina Bert, Heidrun Fink & Meredith A. Fox. (2013) Animal models of the serotonin syndrome: A systematic review. Behavioural Brain Research 256, pages 328-345.
Crossref
Crossref
Jon Jureidini, Anne Tonkin & Elsa Jureidini. (2013) Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents: Prevalence, Efficacy, Risks and Research Needs. Pediatric Drugs 15:5, pages 377-391.
Crossref
Crossref
Fanny Duval, Olivier Flabeau, Julien Razafimahefa, Umberto Spampinato & François Tison. (2013) Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: Possible serotonin syndrome. Movement Disorders 28:10, pages 1464-1464.
Crossref
Crossref
Christine D. Esper & Jorge L. Juncos. 2013. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
411
418
.
Adam Michael Stewart, Jonathan Cachat, Siddharth Gaikwad, Kyle S.L. Robinson, Michael Gebhardt & Allan V. Kalueff. (2013) Perspectives on experimental models of serotonin syndrome in zebrafish. Neurochemistry International 62:6, pages 893-902.
Crossref
Crossref
Paul Gee & Leo Schep. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
179
209
.
Mark Forrest Gordon & Adena N. Leder. 2013. Movement Disorder Emergencies. Movement Disorder Emergencies
217
239
.
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
155
250
.
Joanne Bowes, Andrew J. Brown, Jacques Hamon, Wolfgang Jarolimek, Arun Sridhar, Gareth Waldron & Steven Whitebread. (2012) Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nature Reviews Drug Discovery 11:12, pages 909-922.
Crossref
Crossref
Sébastien Beaune, Jacques Callebert, Frédéric J. Baud, Patricia Risède, Philippe Juvin & Bruno Mégarbane. (2012) Mechanisms of high-dose citalopram-induced death in a rat model. Toxicology 302:2-3, pages 248-254.
Crossref
Crossref
Jonathan E. Sevransky, O. Joseph Bienvenu, Karin J. Neufeld & Dale M. Needham. (2012) Treatment of four psychiatric emergencies in the intensive care unit. Critical Care Medicine 40:9, pages 2662-2670.
Crossref
Crossref
Christopher T. Lum & Stephen M. Stahl. (2012) Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression. CNS Spectrums 17:3, pages 107-120.
Crossref
Crossref
Lincy Subha Lal, Amy Zhuang, Frank Hung, Chun Feng, Rebecca Arbuckle & Michael J. Fisch. (2011) Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center. Supportive Care in Cancer 20:5, pages 983-989.
Crossref
Crossref
Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, Alexander Hillebrecht, Grégori Gerebtzoff, Stefanie Bendels, Fabien Tillier, Jacques Migeon, Holger Fischer, Wolfgang Guba & Manfred Kansy. (2012) Can we discover pharmacological promiscuity early in the drug discovery process?. Drug Discovery Today 17:7-8, pages 325-335.
Crossref
Crossref
Meghan M. Grady & Stephen M. Stahl. (2012) Practical guide for prescribing MAOIs: debunking myths and removing barriers. CNS Spectrums 17:01, pages 2-10.
Crossref
Crossref
Laszlo Urban, Steven Whitebread, Jacques Hamon, Dmitri Mikhailov & Kamal Azzaoui. 2012. Polypharmacology in Drug Discovery. Polypharmacology in Drug Discovery
15
46
.
Rahul Rastogi, Robert A. Swarm & Trusharth A. Patel. (2011) Case Scenario. Anesthesiology 115:6, pages 1291-1298.
Crossref
Crossref
ZS Shaikh, S Krueper & TJ Malins. (2011) Serotonin syndrome: take a closer look at the unwell surgical patient. The Annals of The Royal College of Surgeons of England 93:8, pages 569-572.
Crossref
Crossref
J Mestres, S A Seifert & T I Oprea. (2011) Linking Pharmacology to Clinical Reports: Cyclobenzaprine and Its Possible Association With Serotonin Syndrome. Clinical Pharmacology & Therapeutics 90:5, pages 662-665.
Crossref
Crossref
R. Afshari, R. Afshar & B. Mégarbane. (2011) Tramadol overdose: review of the literatureIntoxication au tramadol : mise au point. Réanimation 20:5, pages 436-441.
Crossref
Crossref
Jon K. Slettedal, Dag Olav V. Nilssen, Morten Magelssen, Else Marit L?berg & Jan Maehlen. (2011) RESPONSE. Neuropathology 31:3, pages 307-308.
Crossref
Crossref
Jon K. Slettedal, Dag Olav V. Nilssen, Morten Magelssen, Else Marit Løberg & Jan Maehlen. (2011) Brain pathology in fatal serotonin syndrome: Presentation of two cases. Neuropathology 31:3, pages 265-270.
Crossref
Crossref
Sobia Nasim, Faraz Jabbar, Asfar Afridi & Brendan D Kelly. (2014) Serotonin toxicity. Irish Journal of Psychological Medicine 28:2, pages i-iv.
Crossref
Crossref
Benjamin Raatjes & Bezalel Dantz. (2011) Trazodone: The Forgotten Antidepressant. Psychiatric Annals 41:3, pages 148-157.
Crossref
Crossref
P Ken Gillman. (2010) CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. Journal of Psychopharmacology 25:3, pages 429-436.
Crossref
Crossref
Hans Rollema, Gary G. Wilson, Theodore C. Lee, Joost H.A. Folgering & Gunnar Flik. (2011) Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Neurochemistry International 58:1, pages 78-84.
Crossref
Crossref
G. Laux & H. Berzewski. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2717
2749
.
Marla Sanzone. 2011. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
2270
2275
.
Senaka Rajapakse, Lakshan Abeynaike & Thanushi Wickramarathne. (2010) Venlafaxine-Associated Serotonin Syndrome Causing Severe Rhabdomyolysis and Acute Renal Failure in a Patient With Idiopathic Parkinson Disease. Journal of Clinical Psychopharmacology 30:5, pages 620-622.
Crossref
Crossref
A. M?nguez-Castellanos. (2010) Cat?strofes en trastornos del movimiento. Neurolog?a 25, pages 24-29.
Crossref
Crossref
Randolph W. Evans, Stewart J. Tepper, Robert E. Shapiro, Christina Sun-Edelstein & Gretchen E. Tietjen. (2010) The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper. Headache: The Journal of Head and Face Pain 50:6, pages 1089-1099.
Crossref
Crossref
P. Ken Gillman. (2010) Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review. Headache: The Journal of Head and Face Pain 50:2, pages 264-272.
Crossref
Crossref
Leslie J. Crofford. 2010. Targeted Treatment of the Rheumatic Diseases. Targeted Treatment of the Rheumatic Diseases
386
396
.
Jacques HamonSteven Whitebread, Valerie Techer-EtienneHelene Le CoqKamal AzzaouiLaszlo Urban. (2009)
In vitro
safety pharmacology profiling: what else beyond hERG?
. Future Medicinal Chemistry 1:4, pages 645-665.
Crossref
Crossref
Mark J. Stillman, Robert G. Kaniecki & Frederick R. Taylor. (2009) Abstracts and Citations. Headache: The Journal of Head and Face Pain 49:5, pages 788-795.
Crossref
Crossref
. (2009) Serotonin Toxicity Revisited. Headache: The Journal of Head and Face Pain 49:5, pages 784-785.
Crossref
Crossref
ERIC SCHUMAN. (2009) Is an FDA alert harming patients?. Journal of the American Academy of Physician Assistants 22:5, pages 55.
Crossref
Crossref